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Abstract 29 
 30 
The production of carnivorous fish such as Atlantic salmon (Salmo salar) is dependent on the 31 
availability of high quality proteins for feed formulations. For a number of nutritional, 32 
strategic and economic reasons, the use of plant proteins has steadily increased over the 33 
years, however a major limitation is associated with the presence of anti-nutritional factors 34 
and the nutritional profile of the protein concentrate. Investigating novel raw materials 35 
involves understanding the physiological consequences associated with the dietary inclusion 36 
of protein concetrates. The primary aim of the present study was to assess the metabolic 37 
response of salmon to increasing inclusion of air-classified faba bean protein concentrate 38 
(BPC) in feeds as a replacement for soy protein concentrate (SPC). Specifically, we tested 39 
treatments with identical contents of fishmeal (222.4 g kg
-1
) and progressively higher 40 
inclusion of BPC (0 g kg
-1
, 111.8 g kg
-1
, 223.6 g kg
-1
, 335.4 g kg
-1
, 447.2 g kg
-1
) substituting 41 
SPC. This study demonstrated a dose-dependent metabolic response to a plant ingredient and 42 
was the first to compare the nutrigenomic transcriptional responses after substitution of 43 
terrestrial feed ingredients such as BPC and SPC without withdrawal of marine ingredients. It 44 
was found that after eight weeks a major physiological response in liver was only evident 45 
above 335.4 g kg
-1
 BPC and included decreased expression of metabolic pathways, and 46 
increased expression of genes regulating transcription and translation processes and the 47 
innate immune response. Furthermore, we showed that the nutritional stress caused by BPC 48 
resembled, at least at hepatic transcriptional level, that caused by soybean meal (included as a 49 
positive control in our experimental design). The outcomes of the present study suggested 50 
that Atlantic salmon parr might efficiently utilize moderate substitution of dietary SPC with 51 
BPC, with the optimum inclusion level being around 120 g kg
-1
in the type of feeds tested 52 
here.   53 
  54 
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1. Introduction 55 
 56 
The sustainable and profitable production of farmed fish is increasingly dependent on their 57 
capacity to perform under dietary regimes based on plant ingredients. Carnivorous fish 58 
species such as Atlantic salmon (Salmo salar) are in high demand due in part to their 59 
beneficial effects on human health as well as the eating quality of their flesh (Whelton et al., 60 
2004, Johnston et al., 2006). To satisfy the increasing demand, high quality protein sources 61 
are required for the formulation of the feeds. The stagnation of wild fisheries and the limited 62 
availability of marine products such as fishmeal (FM) (FAO 2008-2015), traditionally the 63 
ideal protein source for farmed fish (National Research Council, 2011), has increased 64 
pressure for the introduction of alternative raw materials as dietary source of proteins (Gatlin 65 
et al., 2007). In recent years, considerable research has addressed the performance of fish 66 
utilizing alternative feed materials partially or completely substituting FM. Thus far, plant 67 
meals and proteins such as soy have been the most economically viable alternative raw 68 
materials (Gatlin et al., 2007). As a result of ongoing research, modern commercial feeds for 69 
Atlantic salmon utilize significant  inclusion levels of  alcohol-extracted soy protein 70 
concentrate (SPC) as the predominant substitute for FM with, to a lesser extent, a range of 71 
other plant sources (Ytrestøyl et al., 2014). However, the use of SPC as the major alternative 72 
to FM has raised economic (price of soy fluctuates due to high demand from a number of 73 
industries), environmental (over-exploitation of land for farming), strategic (over-reliance on 74 
a single ingredient for feed manufacture) and nutritional (less balanced composition 75 
compared with mixed sources) concerns, prompting continuing research towards the 76 
development of new alternative raw materials to be used in combination with others as 77 
protein concentrate (Burr et al., 2012, De Santis et al., 2015a, Zhang et al., 2012).  78 
To be nutritionally attractive for commercial use, candidate alternative feedstuffs for salmon 79 
feeds must have relatively high protein content (48 %-80 %, ideally higher than 60 %) with a 80 
reasonable balance of essential amino acids, and have low levels of carbohydrates (e.g. fibre 81 
and starch) and antinutritional factors (ANFs) (Gatlin et al., 2007). In addition, good 82 
alternative feed ingredients must be accessible in terms of availability, price and 83 
sustainability. Many of these characteristics are partially dependent on the processing of the 84 
raw material that can greatly affect the resulting feedstuff both nutritionally and 85 
economically. In this respect, protein concentrates from faba bean (Vicia faba) (BPC) possess 86 
a number of favorable characteristics. Recently, we investigated the performance of Atlantic 87 
salmon fed BPC produced by air-classification, a simple and inexpensive process (De Santis 88 
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et al., 2015a). Using a mixture model approach the effects of 16 different combinations of 89 
FM, SPC and BPC on growth and health performance of salmon were assessed using parr in 90 
freshwater. The screening study aimed to identify an appropriate and more confined range of 91 
replacement levels to be applied in seawater studies involving larger fish. It was 92 
demonstrated that salmon efficiently utilized BPC at inclusion levels ranging from 50 to 200 93 
g kg
-1
, partially replacing SPC and/or FM, resulting in increased growth, protein content, fat 94 
content and ash. Evidence of detrimental effects on gut health, commonly observed in 95 
response to dietary inclusion of some vegetable proteins such as soybean meal (SBM) 96 
(Baeverfjord and Krogdahl, 1996, Kortner et al., 2012 and Urán et al., 2008), were not 97 
observed at low levels of inclusions (De Santis et al., 2015a). In contrast, it was shown that a 98 
high inclusion level of BPC (447.2 g kg
-1
) caused mild gut inflammation, comparable but not 99 
as severe as that caused by SBM in post-smolt, seawater adapted salmon. The most important 100 
outcome of that study was that a superior performance was observed in response to mixed 101 
ingredients with the optimum formulation being 200.8 g kg
-1
 FM, 268.9 g kg
-1
 SPC, 117.4 g 102 
kg
-1
 BPC, providing a strong basis for continuing research on BPC utilization in salmon (De 103 
Santis et al., 2015a).   104 
Nutrigenomics is a powerful approach to determine detailed metabolic responses (Mutch et 105 
al., 2005). Recently, nutrigenomics has been used as a tool to study the response of fish to 106 
vegetable dietary proteins, primarily focusing on hepatic or intestinal profiles (De Santis et 107 
al., 2015b, Kortner et al., 2012, Overturf et al., 2012, Panserat et al., 2009, Skugor et al., 2011 108 
and Tacchi et al., 2012,). Specifically in salmon, two studies have reported the hepatic 109 
transcriptional signatures underlying a SBM-induced nutritional stress (De Santis et al., 110 
2015b and Skugor et al., 2011). Further studies are however required to elucidate, understand 111 
and discriminate the general and specific molecular mechanisms underlying utilization of 112 
terrestrial proteins in salmon and fish in general. In this context, the present study aimed to 113 
provide insights into the metabolic responses of salmon parr to the utilization of air classified 114 
BPC as an alternative source of dietary protein.  115 
The overall aim of the present study was to determine and compare hepatic transcriptomes in 116 
Atlantic salmon fed increasing levels of BPC as a substitute for dietary SPC. It is important to 117 
emphasize the rationale behind the feeds tested in this study. The experimental feeds used 118 
(B0, B20, B40, B60, B80) contained the same level of FM and varying levels of two 119 
vegetable proteins: SPC, a refined protein concentrate obtained by aqueous alcohol extraction 120 
of soybean, widely established as a dietary ingredient of farmed Atlantic salmon (Ytrestøyl et 121 
al., 2014) and BPC, a protein concentrate from faba bean produced with the a dry processing 122 
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method (air-classification). In addition, a feed formulated with high levels of SBM (360 g kg
-
123 
1
) was included as positive control to benchmark detrimental effects associated with the plant 124 
material and affected by the processing method. Specifically, the objectives of this study 125 
were to a) establish if the mild effects on gut metabolism, health and impaired growth 126 
observed after high inclusion of BPC (i.e. 447.2 g kg
-1
, ) was reflected in the alteration of 127 
hepatic metabolism, perhaps similar to that observed with high inclusion of SBM (positive 128 
control for nutritional stress); b) provide metabolic evidence to determine the maximum level 129 
of BPC inclusion that is efficiently utilized by salmon; and c) understand the metabolic 130 
processes underlying the improved growth performance observed previously with 131 
low/moderate BPC inclusion (De Santis et al., 2015a) by studying the response to lower 132 
inclusion levels of BPC (i.e. 111.8 g kg
-1
, 223.6 g kg
-1
). A well-described and validated 133 
custom-made Atlantic salmon 44K oligo microarray was utilized for the nutrigenomic 134 
profiling. The present study demonstrated a dose-dependent metabolic response to a plant 135 
ingredient and represents the first report in fish where the transcriptional response to three 136 
terrestrial feed ingredients (BPC, SPC and SBM) is compared.  137 
    138 
2. Materials and Methods 139 
 140 
2.1. Nutritional trial and experimental treatments 141 
The nutritional trial, including full experimental design and diet formulations is described in 142 
detail elsewhere (De Santis et al., 2015a). Briefly, the trial was conducted in the freshwater 143 
facilities of EWOS Innovation (Dirdal, Norway) using a farmed population of Atlantic 144 
salmon parr of average initial weight of around 1.5g. Fish were acclimatized for two weeks 145 
before application of the experimental feeds, which were then fed to quadruplicate tanks. All 146 
feeds were formulated to meet the nutritional requirement of salmon (National Research 147 
Council, 2011) and to have the same protein, lipid and energy content. After eight weeks of 148 
feeding, liver was dissected from 24 individuals per dietary treatment (6 per tank), 149 
immediately placed in RNA Later (Life Technologies, Paisley, UK) and processed as per the 150 
manufacturer’s instructions before being stored at -20°C prior to analyses. For hepatic 151 
transcriptional profiling a subset of five dietary treatments was chosen to span the most 152 
heterogeneous range of growth and health performance and allow to directly comparing SPC 153 
and BPC. The treatments had identical contents of FM (222.4 g kg
-1
) and progressively 154 
higher inclusion of BPC (0 g kg
-1
, 111.8 g kg
-1
, 223.6 g kg
-1
, 335.4 g kg
-1
, 447.2 g kg
-1
) 155 
substituting SPC referred to as diets B0, B20, B40, B60, B80 respectively  (Table 1). In 156 
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addition, a feed formulated with 440 g kg
-1
 FM and 360 g kg
-1
 SBM was also analysed as a 157 
positive reference. Since knowledge on the hepatic transcriptomic response of Atlantic 158 
salmon parr to plant proteins is limited, we used the positive control to benchmark and define 159 
transcriptional profiles that could be supposedly associated with detrimental effects of the 160 
plant. Inclusion levels of SBM similar to those used in this study are in fact well documented 161 
to induce enteropathy in adult salmon (Baeverfjord and Krogdahl, 1996, Krogdahl et al., 162 
2010, Urán et al., 2008, Urán et al., 2009). The feeds analysed in this study corresponded to 163 
20:80:00 (B0), 20:40:40 (B20), 20:60:20 (B40), 20:20:80 (B60), 20:00:80 (B80) and HiSBM 164 
(SBM) from our previous nutritional trial (De Santis et al., 2015a) and were renamed for 165 
clarity of presentation and understanding.  166 
 167 
2.2. Transcriptome analysis 168 
Transcriptomic analysis was conducted using custom-made 4 x 44K Atlantic salmon oligo 169 
microarray slides (Agilent Technologies, Wokingham, UK; ArrayExpress accession no. A-170 
MEXP-2065) described in detail previously (Tacchi et al., 2011). The array design and 171 
laboratory procedures utilized have been widely used and validated in several previous 172 
studies (Betancor et al., 2015a, Betancor et al., 2015b, Bicskei et al., 2014, De Santis et al., 173 
2015b, Morais et al., 2012a, Morais et al., 2012b and Tacchi et al., 2012). The full laboratory 174 
protocol and pipeline for bioinformatics analysis are reported in detail in De Santis et al. 175 
(2015b). Briefly, equal amounts of RNA from three livers of fish from the same tank were 176 
extracted individually using TRI Reagent (Sigma-Aldrich, Dorset, UK), were pooled together 177 
and analyzed as a single biological replicate, thus providing 2 experimental samples per tank 178 
and 8 replicates per dietary treatment. The same RNA pools were used both for 179 
transcriptomic analyses and subsequent RT-qPCR validation. While known to reduce 180 
biological variance, within-tank pooling was deliberately chosen as a strategy to maximize 181 
the informative power of each biological replicate analyzed in this study and justified by 182 
having a non-limiting number of individual samples per experimental unit. The resulting 183 
RNA samples were amplified using TargetAmp™ 1-Round Aminoallyl-aRNA Amplification 184 
Kit, (Epicentre Technologies Corporation, Madison, Wisconsin, USA) following 185 
recommended procedures. Aminoallyl-amplified RNA (aRNA) samples were labelled with 186 
Cy3 dye (GE HealthCare Life Sciences, Buckinghamshire, UK) while a pool of all aRNA 187 
samples was labelled with Cy5 dye (GE HealthCare Life Sciences) and was used as a 188 
common reference. A dual-label common reference design was adopted, where equal 189 
amounts of each individual aRNA sample and the common reference pool were hybridized to 190 
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one array. Throughout the experiment samples were always randomized, avoiding samples 191 
from the same treatment being overrepresented in a particular batch in order to avoid 192 
unintentional biases. Details of microarray experiment have been submitted to ArrayExpress 193 
under accession number E-MTAB-2878.   194 
Data analysis was performed using R v.3.0.1 and Bioconductor v.2.13 (Gentleman et al. 2004 195 
and R Core Team. 2013). Quality control, data pre-processing and identification of 196 
differentially expressed features/genes were conducted using the package limma (Smyth, 197 
2005). Features consistently expressed just above background noise (defined as those features 198 
whose intensity was lower than 5th percentile of the distribution in 75% or more of the 199 
analysed samples) were removed. Multiple testing correction (False Discovery Rate) was 200 
used for differential expression analysis (Benjamini and Hochberg, 1995). Features of the 201 
array were annotated using BLAST 2.2.29+ (blastx) against the entire non-redundant protein 202 
database as well as using the KEGG Automatic Annotation Server to obtain functional 203 
annotations (Altschul et al. 1990 and Moriya et al. 2007). A total of 89.6 % of all probes were 204 
returned with a BLAST annotation (annotation date Dec 2014) with e-value < 0.001, while 205 
59 % of probes were returned with a functional annotation (KEGG identifier) using the 206 
KAAS server. Features representing the same target gene as implied from KEGG annotation 207 
were reduced into a unique value obtained by selecting the feature with the highest F-value 208 
calculated on all contrasts. A new dataset was therefore generated for further analyses where 209 
each gene was represented by a single feature only. Selecting a subset of features resulted in a 210 
dataset of 6740 annotated features targeting unique genes.  211 
 212 
2.3 Data mining 213 
Similarity between treatments. Overall similarity between experimental treatments was 214 
estimated by association between gene expression profiles analyzed using the limma function 215 
genas (subset = Fpval). This analysis determined the correlation based on the log transformed 216 
fold change (log2FC) on a feature-by-feature basis. The algorithm also allowed discriminating 217 
true biological correlation (ρbiol) from technical correlation (ρtech) (Majewski et al., 2010). 218 
Overview of differential expression. All figures based on differentially expressed genes were 219 
plotted using the R package ggplot2 (Wickham, 2009). For figures involving functional 220 
information, the KEGG database was used as the preferred classification system.  221 
Gene-Set Enrichment Analysis (GSEA). Unique annotated sequences were analyzed using the 222 
R function gage of the software package gage [Generally Applicable Gene-set Enrichment, 223 
(Luo et al., 2009)] to identify mechanistic changes as suggested by coordinated expression 224 
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changes in gene-sets. For completeness, two types of test were performed: 1 direction (1d), 225 
testing all genes in a gene-set moving towards the same direction; and 2 directions (2d), 226 
testing genes in a gene-set that move towards both directions. Gene-sets with a q-value < 0.01 227 
were considered significant, where the q-value represented the p-value adjusted for false 228 
discovery rate (Benjamini and Hochberg, 1995). KEGG classification was used for these 229 
analyses and all figures were produced using the software package ggplot2.   230 
 231 
2.4. RT-qPCR validation 232 
Validation of microarray expression data was performed by reverse transcriptase RT-qPCR. 233 
A total of six targets were analyzed, including a reference and five target features. EF1a 234 
(Table 2) was used for normalization and was selected based on stability across the analyzed 235 
treatments from a number of candidate reference genes (data not reported). The expression of 236 
the target genes was normalized using the delta-delta Ct approach (Pfaffl, 2001). Target 237 
genes for validation investigated in this study were selected based on various criteria from the 238 
microarray dataset (e.g. large fold change, p value < 0.0001, 0.01 < p value < 0.05, etc.). 239 
Primers for the target genes were designed using the program PerlPrimer (Marshall, 2004) 240 
either to overlap the probe sequence or, where not possible, in proximity of it to ensure 241 
sufficient validation by amplification of the same target sequence. Protocols for reverse 242 
transcription and qPCR were described in detail previously (Bicskei et al, 2014). Primers 243 
utilized for validation and results are provided in Supplementary Table 1 and Supplementary 244 
Fig. 1, respectively.   245 
 246 
3. Results 247 
 248 
3.1 Somatic, biochemical and histological data 249 
Results of somatic, biochemical and histological analyses were presented and discussed in 250 
detail previously (De Santis et al., 2015a) and a summary is provided in Fig. 1. Briefly, for 251 
the treatments analysed in this study statistical modeling of growth data indicated that 252 
maximum weight gain over the 8-weeks experimental period (~ 10.5 g) was achieved in 253 
response to feed B20, whereas feeds B0 and B40 had a marginally lower effect on weight 254 
gain (~ 10.2 g). At BPC inclusion levels higher than 223.6 g kg
-1
 (B40) fish performance, 255 
measured in terms of weight gain, deteriorated resulting in ~ 9.1 g in response to B60 and ~ 256 
7.3 g in response to B80. Protein and oil content varied marginally within a range of 0.5% 257 
with the highest protein and fat content generally resulting in response to B20 and B40. For 258 
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enteritis assessment, only scores for supernuclear vacuoles (SNV) and goblet cells (GC) in 259 
the posterior intestine resulted significantly different between dietary treatments. Fish fed 260 
with SBM feed had the highest scores followed by those fed B80. Overall, fish fed B0, B20, 261 
B40 and B60 had GC and SNV scores similar to fish fed with a negative control diet (Fig. 1). 262 
Notably, fish fed the SBM positive control developed an marginally inflamed posterior 263 
intestine (only GC and SNV) but did not show significant growth retardation. Further insights 264 
into these results can be found in De Santis et al. (2015a).  265 
 266 
3.2 Overview of transcriptomic analysis  267 
Hepatic transcriptome analysis indicated that there was a substantially different response in 268 
salmon when only SPC (B0) or BPC (B80) was included as a dietary source of protein. 269 
Specifically, the response to the two extreme treatments B0 and B80 differed by 2692 genes 270 
that were expressed differently (p value < 0.05). The salmon hepatic transcriptome responded 271 
in a dose-dependent manner with an evident correlation between inclusions of BPC and 272 
number of differentially expressed genes (i.e. DEGB0-B20 = 6, DEGB0-B40 = 295, DEGB0-B60 = 273 
1503, DEGB0-B80 = 2692) (Supplementary Fig. 1). The majority of expression differences 274 
were relatively low (i.e. absolute fold change < 2) with the largest changes observed in the 275 
contrast B0-B80. The biological correlation (ρbiol), statistically determined on expression 276 
values (LogFC), revealed that moderate inclusions of BPC (i.e. B20 and B40) did not 277 
significantly affect the salmon hepatic transcriptome (ρbiolB0-B20 = 0.961, ρbiolB0-B40 = 0.897) 278 
and differences emerged above BPC inclusions of 335.4 g kg
-1
 (ρbiolB0-B60 = 0.639, ρbiolB0-279 
B80 = 0.052) (Fig. 2). By comparison of the treatments with the hepatic response to the SBM 280 
treatment it was evident that B80 and to a lesser extent B60 were more similar to SBM than 281 
treatments with lower levels of BPC (i.e. B0, B20 and B40) (Supplementary Fig 2). 282 
 283 
3.3 Gene Set Enrichment Analyses (GSEA) 284 
To elucidate the mechanistic changes that occurred in salmon liver in response to the 285 
substitution of dietary SPC with BPC, GSEA was performed using gage. Results of GSEA 286 
are shown in Fig. 3 (1d) and Fig. 4 (2d), while details on specific contrasts are reported in 287 
Supplementary Tables 2 & 3. The result of the 1d analysis was informative in that it indicated 288 
the overall direction of change of the genes underlying each gene-set (Fig. 3). The overall 289 
trend and similarity between treatments was also immediately evident from this analysis and 290 
confirmed the results mentioned above indicating that the responses to diets B20 and B40 291 
were similar to that of B0, whereas B60 and B80 differed significantly. GSEA also confirmed 292 
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that the profile of fish fed diets B60 and B80 were closely comparable to the dietary 293 
transcriptional signatures observed in response to a SBM-induced nutritional stress, used as a 294 
positive control in the trial. The stress signature, identifiable both in response to SBM and 295 
B60/B80, included a) the down-regulation of all metabolic pathways including two pathways 296 
of the endocrine and digestive system (PPAR signaling pathway, vitamin  absorption); b) the 297 
up-regulation of most pathways involved in genetic information processing or protein 298 
synthesis (e.g. ribosome biogenesis, protein export, RNA degradation, RNA transport, etc.); 299 
c) up-regulation of a number of organismal system pathways, which included immune system 300 
(cytosolic-DNA sensing pathways, natural killer cell cytotoxicity and Fc epsilon RI signaling 301 
pathway) and digestive functions (pancreatic secretion, protein digestion and absorption); and 302 
d) a marked and significant down-regulation of proteasome-related genes and oxidative 303 
phosphorylation. Two further notable features that emerged through GSEA were a set of 304 
pathways only down-regulated by high levels of BPC and not by low BPC levels or SBM, 305 
including glycolysis/gluconeogenesis, amino acid metabolism (phenylalanine, tryptophan, 306 
valine-leucine-isoleucine degradation, glycine-serine-threonine), PPAR signaling pathway 307 
and vitamin digestion and absorption, and a group of gene-sets consistently down-regulated 308 
in response to diet B40 that included ribosome, protein processing in the endoplasmatic 309 
reticulum, protein export, N-glycan biosynthesis and terpenoid backbone biosynthesis (Fig. 310 
3).           311 
In contrast to the 1d analysis, the 2d analysis shown in Fig. 4 assumed that genes underlying 312 
a certain gene-set changed in both directions. This analysis is particularly effective to identify 313 
differential expression in metabolic pathways that often include more complex gene networks 314 
(Luo et al., 2009). This test revealed that at least two pathways (steroid biosynthesis and 315 
PPAR signaling pathways) were affected in all treatments including BPC (see Supplementary 316 
Table 3 for details). In addition, steroid biosynthesis was also the most affected 2d pathway 317 
(highest magnitude and lowest q value) in response to high inclusion of BPC (BPC60 and 318 
BPC80) as well as SBM, followed by glutathione metabolism. The latter was not altered 319 
when dietary BPC was included in small proportions. Lipid digestion and absorption and 320 
biosynthesis of unsaturated fatty acids also clustered with these pathways suggesting that 321 
lipid metabolism was a particularly affected process. Finally, a large group of metabolic 322 
pathways was significantly affected by diet B80, and to a slightly lesser extent also by diets 323 
B60 and SBM, including glycolysis/gluconeogenesis, citrate cycle, pentose phosphate 324 
pathway, pyruvate metabolism and other metabolic pathways (Fig. 4). As for the 1d analysis, 325 
a set of pathways primarily affected by high BPC, but not by SBM, was identified through 326 
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the 2d test and included amino acid metabolism (tyrosine and beta-alanine), digestive 327 
functions (carbohydrate digestion and absorption and pancreatic secretion) and the immune 328 
response (complement and coagulation cascades).  329 
 330 
3.4 BPC-specific effects 331 
Through the GSEA described in section 3.2, a set of pathways specifically affected by high 332 
dietary inclusions of BPC, but not SBM, was identified. These pathways included those 333 
regulating digestive functions (vitamins and carbohydrates digestion and absorption, 334 
pancreatic secretion), amino acid metabolism (phenylalanine, tyrosine, glycine-serine-335 
threonine, tryptophan, etc.) and the complement and coagulation cascades. To identify the 336 
specific mechanisms affected by BPC and not SBM, the genes underlying these processes 337 
were analyzed in detail. Genes (by process) specifically affected by high levels of BPC 338 
included: digestive processes) apolipoprotein A1 and B, membrane transporters such as the 339 
MFS transporter SP and OPA families, and sodium/potassium-transporting ATPase (subunits 340 
alpha and beta) and transcobalamin-2 (Fig. 5); amino acid metabolism) genes regulating 341 
glycine-serine-threonine metabolism (i.e. glycine N-methyltransferase, serine-glyoxylate 342 
transaminase, glycine hydroxymethyltransferase, dimethylglycine dehydrogenase, etc.), 343 
phenylalanine metabolism (phenylalanine-4-hydroxylase and 4-hydroxyphenylpyruvate 344 
dioxygenase) and tryptophan metabolism (tryptophan 2,3-dioxygenase) (Fig. 6); complement 345 
and coagulation cascades) complement components (C4, C5, CR3b/4b, C1, C8) and 346 
coagulation factors (F2, F5, F8, F13) (Fig. 7).  347 
 348 
3.5 RT-qPCR validation of array data  349 
Five features were analyzed by RT-qPCR in a subset of three treatments (B0, B40, B80) to 350 
validate the data obtained with the oligo microarray. Five targets were considered sufficient 351 
as the custom-made 44K salmon array has been successfully validated in several previous 352 
studies (Betancor et al., 2015b, Bicskei et al. 2014, Carmichael et al. 2013 and Morais et al. 353 
2011). RT-qPCR data were comparable to that from the array showing identical direction of 354 
changes with comparable fold-changes, treatment variance and p values (Supplementary Fig. 355 
3).  356 
 357 
4. Discussion 358 
 359 
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The overarching aim of this study was to gain insight into the consequences of the utilization 360 
of BPC as a dietary protein source in Atlantic salmon and it was the first investigation of its 361 
kind to study the metabolic response to this protein source. Commercially used SPC was 362 
substituted with increasing levels of BPC produced using relatively simple and inexpensive 363 
air-classification technology. To benchmark transcriptional profiles supposedly associated 364 
with detrimental effects of plant material, a feed including high levels of SBM and known to 365 
induce enteritis and nutritional stress was used as a positive control of degraded fish welfare. 366 
The metabolic status of fish was determined by analysis of the hepatic transcriptome since the 367 
liver is arguably the most important metabolic organ playing key roles in support of 368 
digestion, protein and hormone synthesis and detoxification. Specifically, we sought to: a) 369 
describe and establish differences in the hepatic transcriptome between  high inclusion of 370 
BPC (i.e. 447.2 g kg
-1
), where some detrimental effects on gut health and growth were 371 
observed, and the SBM reference that caused some clinical sign of enteritis in the gut but not 372 
growth retardation (De Santis et al., 2015a); b) provide metabolic evidence to determine the 373 
maximum level of BPC inclusion that is efficiently used by Atlantic salmon; and c) describe 374 
the metabolic responses, where possible, underlying the improved performance observed with 375 
moderate inclusion of BPC (i.e. 111.8 g kg
-1
, 223.6 g kg
-1
). It is important to emphasize that 376 
the experimental feeds used in this study contained the same level of FM and that the SBM 377 
positive control was formulated with a higher level of FM than the remaining treatments. 378 
Therefore, the results discussed herein are solely associated with properties of the plant 379 
protein sources and not with a withdrawal of marine ingredients.    380 
The physiological response to dietary SBM is the best characterized nutritional stress caused 381 
by a plant protein source in fish and is supported by histological, biochemical and 382 
transcriptional data in tissues such as the intestine and more recently, liver (De Santis et al., 383 
2015b, Kortner et al. 2012, Kortner et al., 2013, Overturf et al., 2012, Skugor et al., 2011 and 384 
Tacchi et al., 2012). For this reason, a SBM-rich feed was chosen as the positive reference to 385 
induce degraded fish welfare in this study. Histological analysis of the posterior intestine 386 
aiming to assess the presence of gut inflammation revealed that while salmon parr fed the 387 
positive reference were the most affected amongst all treatments, they only developed a mild 388 
gut inflammation primarily involving a reduction of supernuclear vacuoles and increased 389 
number of goblet cells. Despite the high level of SBM used in the diet (360 g kg
-1
), the 390 
detrimental effects obtained were only partially comparable to those well documented in 391 
studies performed with post-smolt, seawater adapted salmon (Baeverfjord and Krogdahl, 392 
1996, Urán et al., 2008, Urán et al., 2009). Our results were in line with those recently 393 
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reported in Atlantic salmon parr suggesting that early life stages of salmon might be either 394 
more tolerant to inclusions of plant material in the feed or having a less pronounced immune 395 
response in the gut due to a partially developed immune system (Sahlmann et al. 2015). 396 
Despite the response in the gut, however, a significant alteration of the hepatic transcriptome 397 
was observed in comparison to the control feed B0 containing only SPC. In addition, we 398 
demonstrated that the hepatic transcriptional response of salmon fed very high inclusion of 399 
BPC was largely consistent with that caused by SBM. These results were informative 400 
considering that SBM and SPC are obtained from the same seed through different processing. 401 
The dietary transcriptional signatures underlying the nutritional stress (very high BPC- or 402 
SBM-induced) included the down-regulation in liver of metabolic pathways including energy 403 
metabolism, digestive functions (except pancreatic secretion) and proteasome-related genes. 404 
Up-regulated processes included protein synthesis as well as pathways associated with the 405 
immune response. Interestingly, this signature was consistent with that observed in salmon 406 
smolts fed high levels of SBM in saltwater (De Santis et al. 2015b, Skugor et al. 2011), 407 
although contrarily to the intestinal inflammatory response that appeared to be only marginal, 408 
the response of the liver seemed more pronounced.  This might suggest that in early life 409 
stages such as parr the liver might play a more central role in facing the nutritional challenge 410 
of plant proteins, an observation that supports other studies in parr showing that this organ is 411 
one of the first to develop (Sahlmann et al. 2015).  412 
The majority of transcriptional changes observed in the liver in response to B80 (and partially 413 
to B60) were common to those developing in response to SBM, thus suggesting that these 414 
changes are likely to be associated with the processing of the plant rather than the nutritional 415 
profile of soy and faba bean. The processing method is in fact critical in determining the level 416 
of ANFs remaining in protein concentrates (Krogdahl et al., 2010). This hypothesis is 417 
supported by the fact that the control diet B0 contained more soy-derived protein (from SPC) 418 
and less marine proteins (FM) than the positive control SBM and if detrimental effects were 419 
associated with the nutritional profile of the soybean, these should be more evident in the 420 
experimental feed B0. Thus, SBM had a nutritional profile different to  any other 421 
experimental feed tested in this study due to the significantly higher content of FM (440 g kg
-
422 
1 
vs 222.4 g kg
-1
), arguably the best protein source for fish. The effects of ANFs have been 423 
widely investigated and can have a significant impact on digestive capacity, metabolism and 424 
health of farmed animals in general (Krogdahl et al., 2010). For example, the glycoprotein 425 
conglycinin, a seed storage protein, can induce oxidative damage and inflammation in fish 426 
resulting in an impaired endogenous antioxidant response as well as negatively affecting 427 
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hepatic lipid metabolism (Yamazaki et al., 2012 and Zhang et al., 2013). Similarly, the heat-428 
stable glycosides, saponins, can impact lipid metabolism, negatively affecting plasma 429 
cholesterol levels, bile salt concentrations and hepatic bile synthesis in salmon and other 430 
organisms (Francis et al., 2001 and Gu et al., 2014), and trigger the response of components 431 
of the innate immune response in fish (Fuentes-Appelgren et al., 2014). Finally, trypsin 432 
inhibitors may increase pancreatic hyperactivity with over secretion of digestive enzymes 433 
such as chymotrypsins, elastases and carboxypeptidases into the intestinal lumen with 434 
subsequent loss of resources (i.e. sulphur-rich amino acids) in the faeces and as a result lead 435 
to growth suppression and also affect protein and amino acid digestibility (Rosewicz, 1989, 436 
Sarwar Gilani et al., 2012).  437 
Evidence of impaired metabolism in the liver was observed both in response to high BPC and 438 
SBM, including a significant decrease of lipid, carbohydrate, energy and amino acid 439 
metabolism. Liver is arguably the most active metabolic tissue and, as such, it is rich in 440 
mitochondria to sustain its metabolic functions. One hypothesis to explain the observed 441 
reduced metabolism is that high levels of dietary BPC or SBM caused a degree of oxidative 442 
stress resulting in impaired mitochondrial function. This was supported by the fact that beans, 443 
and faba beans in particular, are potentially potent oxidative stressors due to the presence of 444 
vicin, a toxic alkaloid glycoside (Lattanzio et al., 1983). The oxidative potential of vicin is 445 
well known in humans, where consumption of faba beans in individuals with glucose-6 446 
phosphate dehydrogenase deficiency causes the disease favism associated with the inability 447 
of erythrocytes to tolerate vicin-induced oxidative stress (Cappellini and Fiorelli, 2008). 448 
Activation of glutathione metabolism indicated by GSEA supported this hypothesis. In fact, 449 
glutathione plays an important role as a cofactor of enzymes with antioxidant functions 450 
protecting the cell from oxidative damage (Pompella et al., 2003). A second hypothesis to 451 
explain reduced metabolic functions is reduced nutrient uptake from the intestine due either 452 
to effects such as the inhibition of lipid absorption by saponins (Gu et al., 2014) or by directly 453 
affecting digestion itself (digestibility). Notably, in this study genes coding for pancreatic 454 
enzymes were up-regulated after feeding high levels of BPC or SBM in salmon parr, a trend 455 
also observed in post-smolt salmon (De Santis et al., 2015b). The increased levels of these 456 
digestive enzymes in salmon liver might resemble the condition known as “hyperactive 457 
pancreas” described in mammalian models where increased synthesis of pancreatic enzymes 458 
is observed after exposure to plant-born protease inhibitors (De Santis et al., 2015b and 459 
Sarwar Gilani et al., 2012). These hypotheses are not mutually exclusive, however a 460 
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significant reduction of nutrient uptake seems less likely at least in the case of fish fed SBM, 461 
since degraded growth was not observed within the timeframe of the experiment.  462 
In contrast to genes regulating metabolic functions that showed consistently decreased 463 
expression, a number of other genes showed the opposite trend following the nutritional 464 
stress (B80, SBM). These included mainly transcripts coding for factors involved in protein 465 
synthesis such as, for example, the biogenesis of ribosomes, RNA transport and degradation, 466 
protein export and protein processing in the endoplasmatic reticulum, indicating an increased 467 
potential for net protein synthesis and export. This observation, together with data indicating 468 
reduced metabolic functions, might suggest that high dietary BPC as well as SBM may 469 
induce an investment of energy in other directions, for example towards the synthesis of 470 
proteins involved in detoxification or immune responses. The liver receives most of its blood 471 
supply through the portal vein that connects this organ to the intestine. The blood flowing to 472 
the liver is rich in nutrients that are digested in the intestinal lumen and absorbed by the 473 
enterocytes, but it may also contain bacterial products, toxins and food antigens. The ingress 474 
of unwanted products may be facilitated by enterocyte disruption caused by the local 475 
inflammation generally observed in response to plant material and also detected after feeding 476 
high levels of BPC and SBM in salmon parr (De Santis et al., 2015b).  477 
There is evidence that liver plays an important role in the immune response towards 478 
pathogens (Gao et al, 2008). The results of this study suggest that only a marginal 479 
inflammatory response was seen at intestinal level, whereas in the liver we identified at least 480 
three interrelated mechanisms that might indicate an activation of the first line of defense 481 
against pathogens. These included the up-regulation of the cytosolic DNA sensing pathway, a 482 
family of pattern recognition receptors that are responsible for the activation of the response 483 
against the invading pathogen (Takaoka and Taniguchi, 2008). The activation of pattern 484 
recognition receptors is responsible, amongst other, of triggering an extracellular response 485 
that involves the recruitment of natural killer cells for the elimination of the infected cells. 486 
Genes involved in the natural killer cell-mediated cytotoxicity were also up regulated. One 487 
last important mechanism suggested by our results was the possible involvement of the 488 
complement cascade, which can occur through three different biochemical pathways: 489 
classical, alternative and lectin pathways (Degn and Thiel, 2013). The classical pathway 490 
requires antigen-antibody complexes for activation and is mediated by complement 491 
component 1 protein complex (C1q, C1s, C1r). The expression of genes coding for elements 492 
of the classical pathway (e.g. C1-subcomponents) were down-regulated by the use of high 493 
levels of BPC but not when low levels or SBM were used. The other two routes leading to the 494 
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common terminal pathway are the alternative and lectin pathways, which are mediated by 495 
complement component 3 and mannan-binding serine protease-I, respectively (Janeway, 496 
2001 and Janeway and Travers, 1994). Mediators of the alternative and lectin pathways (e.g. 497 
C3 and MASP-1) were significantly up-regulated in response to high BPC and, to a lesser 498 
extent, SBM. The up-regulation of genes regulating the lectin pathway was also observed in 499 
the liver of salmon smolts fed high levels of dietary SBM (De Santis et al., 2015b), whereas 500 
in zebrafish it was showed that dietary supplementation of ANFs such as saponin resulted in 501 
an increased innate immune response as indicated by increased number of granulocytes 502 
associated with the digestive tract as well as higher expression of genes in the larvae known 503 
to regulate this response including C3 (Fuentes-Appelgren et al., 2014).   504 
The hepatic transcriptional response of salmon to diets B60 and B80 was in several aspects 505 
comparable to that observed in response to the SBM control, suggesting that high levels of 506 
these two protein concentrates may induce similar detrimental effects on fish. However, three 507 
major processes were identified in which salmon responded differently. These processes 508 
could mirror the slower growth rate observed in B60 and B80 compared with SBM, in 509 
contrast with the remaining processes that should relate to the specific response to ANFs. 510 
Understanding these differences could help clarify the issues of utilization of BPC as a 511 
dietary protein source. The first major difference concerned amino acid metabolism, where 512 
three genes including dimethylglycine dehydrogenase, glycine N-methyltransferase and 513 
betaine-homocysteine S-methyltransferase were down-regulated in response to high BPC but 514 
not SBM and they participate in the synthesis of glycine from choline. Soybean is a rich 515 
source of choline in the form of phosphatidylcholine and, although most of this is 516 
concentrated in the oil fraction, a proportion of choline still remains in the protein concentrate 517 
(Menten et al., 1997). In addition, BPC-related down-regulation of genes coding for catabolic 518 
enzymes regulating tryptophan (tryptophane 2,3 dioxygenase) and phenylalanine 519 
(phenylalanine 4-hydroxilase and 4-hydroxyphenylpyruvate dioxygenase) degradation was 520 
observed. This might be a response to different dietary levels of the aromatic amino acids 521 
supplied by BPC compared to SPC and SBM. For example, the level of tryptophan in BPC 522 
used in this trial was 40 % lower than that measured in SPC (De Santis et al., 2015a). The 523 
differential expression of these catabolic genes might explain the utilization of the resources, 524 
however are unlikely to result in major differences at phenotypic level. In fact, while not 525 
every amino acid was balanced in the diet, they all met the nutritional requirement of salmon 526 
(De Santis et al., 2015a). Finally, differences were also identified in the expression of 527 
apolipoprotein-B and to a lesser extent apolipoprotein-A1, involved in the formation of 528 
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chylomicrons and consequently in the transport of vitamins and triacylglycerol, as well as in 529 
the expression of transcobalamin-2 necessary for the uptake of vitamin B12. These differences 530 
however were only noted above BPC inclusion of 335.4 g kg
-1
 and not below that level when 531 
a more equal contribution of SPC and BPC was provided in the diet.                 532 
Testing novel raw material such as plant protein can be challenging. The presence of 533 
xenobiotics, together with the fact that these foreign compounds may have individual as well 534 
as synergistic actions on the physiological response encourage studies to provide an overall 535 
view of the physiological state of the animal. The present investigation provided a profile of 536 
the hepatic transcriptome response to dietary BPC in salmon. The overall metabolic status of 537 
salmon was generally not significantly altered by inclusion of BPC up to a level of 223.6 g 538 
kg
-1
 (B40) and feeds below these inclusions resulted in a similar response. The molecular 539 
outcome of the present study supported our previous results describing the effects on growth 540 
performance and health indicating that Atlantic salmon could tolerate moderate substitution 541 
of dietary SPC with BPC, with the optimum being 117.4 g kg
-1
 (De Santis et al., 2015a). In 542 
addition, it was shown that BPC inclusions above 335.4 g kg
-1
 (B60) triggered a 543 
transcriptional response that suggested ongoing nutritional stress detrimental for fish health 544 
and welfare, similar to that observed at maximum inclusions of BPC (447.2 g kg
-1
) and in 545 
response to 360 g kg
-1
 SBM. Our previous study showed that diet B60 did not result in gut 546 
inflammation and resulted in only a minor loss of performance, however data from the 547 
present study demonstrated that this level of substitution exceeded the amount that can be 548 
efficiently metabolized and utilized by salmon at the hepatic level a particularly useful 549 
information considering that post-smolt, seawater adapted salmon might be more susceptible 550 
to these level of inclusion compared to parr. Future studies should therefore focus on the use 551 
of dietary BPC in seawater smolts not exceeding inclusion levels of 223.6 g kg
-1
 and include 552 
a wider range of sampling times and tissues to fully understand the utilization of plant 553 
proteins in salmon. Further, the possibility that salmon could develop detrimental effects 554 
when fed a diet with BPC inclusion level below 223.6 g kg
-1
 over longer period of feeding 555 
should be investigated.   556 
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Figure Legends 737 
Figure 1. Summary of somatic, histological and biochemical data extracted from De 738 
Santis et al., (2015a). From top left moving clockwise: a) contour plot showing weight gain 739 
(g fish) over eight weeks, “X” indicate feeds tested in the original study while red dots 740 
indicate feeds considered in the present study (B0, B20, B40, B60, B80; see Table 1 for 741 
formulations). The contour lines join points of equal growth. Lighter colours denote regions 742 
with higher weight gain; b) Modelled effect of feeds on supernuclear vacuoles (SNV) and the 743 
goblet cells (GC) in the posterior intestine. Mean and 95% confidence interval are shown. 744 
Positive number means a more severe effect. Blue dotted line denotes the mean score 745 
assigned to the positive control for enteritis while red dotted line that of fish fed the negative 746 
control; c) Contour plot showing the whole body protein content of fish; d) Contour plot 747 
showing the whole body oil content of fish. For further information on these results the reader 748 
is referred to the original publication (De Santis et al., 2015a). 749 
Figure 2. Association of gene expression profiles as analysed by genas (limma package). 750 
Green ellipses denote the biological correlation (ρbiol) compared to the technical correlation 751 
(ρtech) represented in purple as calculated by the algorithm. Dots represent gene expression 752 
log2 transformed fold change, reported relatively to the common reference pool.  753 
Figure 3. Heatmap comparing results of GSEA (1d). The figure was generated using 754 
heatmap.2 (package gplots) (Warnes et al. 2013). Hierarchical clustering (Euclidean distance) 755 
was performed on individual expression values (i.e. “statistics”) calculated using the gage 756 
algorithm. All expression values are reported compared to B0. For clarity, only pathways that 757 
were significantly different (q < 0.01) in at least one contrast are plotted. All replicates 758 
analyzed are shown (BPC, n = 8; SBM, n = 6), represented by an individual square. 759 
Figure 4. Heatmap comparing results of GSEA (2d). The figure was generated using 760 
heatmap.2 (package gplots) (Warnes et al. 2013). Hierarchical clustering (Euclidean distance) 761 
was performed on individual expression values (i.e. “statistics”) calculated using the gage 762 
algorithm. All expression values are reported compared to B0. For clarity, only pathways that 763 
were significantly different (q < 0.01) in at least one contrast are plotted. All replicates 764 
analyzed are shown (BPC, n = 8; SBM, n = 6), represented by a square. 765 
Figure 5. Expression of genes regulating digestive functions. Heatmap plotting Log2-766 
transformed fold change expression values (relatively to B0) of genes regulating pancreatic 767 
secretion, vitamin digestion and absorption and carbohydrate digestion and absorption. Genes 768 
were selected according to KEGG classification. For clarity, only the most variable genes 769 
24 
 
were selected (Interquartile range > Log2(1.3)). Note: Fig. 5, Fig. 6 and Fig. 7 are not on the 770 
same scale. Genes highlighted in yellow were only affected by high concentration of BPC but 771 
not SBM.  772 
Figure 6. Expression of genes regulating amino acid metabolism. Heatmap plotting Log2-773 
transformed fold change expression values (relative to B0) of genes regulating amino acid 774 
metabolism. Genes were selected according to KEGG classification. For clarity, only the 775 
most variable genes were selected (Interquartile range > Log2(1.2)). Note: Fig. 5, Fig. 6 and 776 
Fig. 7 are not on the same scale. Genes highlighted in yellow were only affected by high 777 
concentration of BPC but not SBM. 778 
Figure 7. Expression of genes regulating complement and coagulation cascades. 779 
Heatmap plotting Log2-transformed fold change expression values (relative to B0) of genes 780 
regulating the complement and coagulation cascades. Genes were selected according to 781 
KEGG classification. For clarity, only the most variable genes were selected (Interquartile 782 
range > Log2(1.15)). Note: Fig. 5, Fig. 6 and Fig. 7 are not on the same scale. Genes 783 
highlighted in yellow were only affected by high concentration of BPC but not SBM. 784 
  785 
Legend to Supplementary Figures 786 
Supplementary Figure 1. Plot of genes that resulted differentially expressed (p < 0.01, 787 
absolute fold change > 1.5) for the contrasts B80 vs B0, SBM vs B0 and SBM vs B80. 788 
Hierarchical clustering (Euclidean distance) was performed on individual expression values. 789 
The figure was generated using heatmap.2 (package gplots) (Warnes et al. 2013). 790 
Supplementary Figure 2. Pairwise comparison of number of unique differentially expressed 791 
genes (DEG) in hepatic transcriptomes between fish fed the different dietary treatments. 792 
Features targeting the same gene were excluded hence the number represents features 793 
targeting unique genes affected by each dietary treatments.   794 
Supplementary Figure 3. Validation of the expression of five probes analysed using array 795 
technology and RT-qPCR.  796 
 797 
  798 
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Table 1. Formulations of experimental feeds  799 
Ingredients B0 B20 B40 B60 B80 
LT FM 222.4 222.4 222.4 222.4 222.4 
Selecta SPC 60 448.2 336.2 224.1 112.1 0.00 
Fabaqua 62-65 0.00 111.8 223.6 335.4 447.2 
Wheat gluten 80.0 80.0 80.0 80.0 80.0 
Tapioca 76.1 76.3 76.6 76.7 77.0 
Vitamin, Mineral and Pigments premixes 56.6 56.6 56.6 56.6 56.6 
Synthetic amino acids 8.3 9.1 10.0 10.7 11.5 
Fish oil 98.4 97.6 96.8 96.1 95.3 
Lecithin source 10.0 10.0 10.0 10.0 10.0 
Formulation of the experimental feeds used in the study. All values are represented as g kg
-1
. 800 
Further details on dietary formulations can be found in De Santis et al., 2015a) 801 
  802 
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Supplementary Table 1. RT-qPCR primers used for validation of microarray data. 833 
Probe 
Name 
Gene Description Forward Primer  Reverse Primer Efficie
ncy 
NA Elongation Factor 1A GCACCACGAGACCCT
GGAAT 
CACGTTGCCACGAC
GGATAT 
101.4
% 
Ssa#S3028
0356 
Acyl-CoA desaturase CCCTAAACCACCGAT
GAGAC 
CAAGAAGCACAAA
GCAGTCC 
101.6
% 
Ssa#STIR
40430 
elongation of very long chain 
fatty acids-like 6 
CTGATGTTTCTTTGGC
TCCC 
CCCGCATTCTTCAT
AAGTACC 
105.2
% 
Ssa#S1888
2119 
Apolipoprotein F TAGTACCGTTACAAT
AGTCCCTG 
TCATCCCTCTTAGA
CCACCT 
91.6% 
Ssa#STIR
08354 
chymotrypsinogen b1 TCCCTGTCCATATTGC
TATGTC 
TGTCATGTTCAGTT
CAGACCA 
104.9
% 
Ssa#S3023
7369 
glucagon I AAGAAAGCAGAAAG
CAACGG 
GGCTTCCCTTCAAC
CTACAG 
94.6% 
 834 
  835 
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Supplementary Table 2.  Complete results of GSEA (1d test) of treatments compared to B0. 836 
Gene Set Biological 
Process 
Class Number 
of genes 
Magnitude q Value 
B20 vs B0 
Ribosome GIP Translation 119 -1.37 0.017 
Proteasome GIP Folding, sorting and 
degradation 
41 -1.32 0.017 
Protein digestion and absorption Organismal 
Systems 
Digestive system 43 1.33 0.030 
B40 vs B0 
Ribosome GIP Translation 119 -2.57 0.000 
Protein processing in endoplasmic 
reticulum 
GIP Folding, sorting and 
degradation 
119 -1.96 0.000 
N-Glycan biosynthesis Metabolism Glycan biosynthesis 
and metabolism 
37 -1.58 0.001 
Terpenoid backbone biosynthesis Metabolism Metabolism of 
terpenoids and 
polyketides 
17 -1.56 0.001 
Protein export GIP Folding, sorting and 
degradation 
21 -1.49 0.001 
Aminoacyl-tRNA biosynthesis GIP Translation 28 -1.33 0.005 
Proteasome GIP Folding, sorting and 
degradation 
41 -1.26 0.009 
DNA replication GIP Replication and 
repair 
33 -1.08 0.047 
B60 vs B0 
Oxidative phosphorylation Metabolism Energy metabolism 106 -2.62 0.000 
Aminoacyl-tRNA biosynthesis GIP Translation 28 -2.00 0.000 
Propanoate metabolism Metabolism Carbohydrate 
metabolism 
22 -1.74 0.000 
Cardiac muscle contraction Organismal 
Systems 
Circulatory system 49 -1.67 0.000 
Glyoxylate and dicarboxylate 
metabolism 
Metabolism Carbohydrate 
metabolism 
20 -1.65 0.000 
Biosynthesis of unsaturated fatty acids Metabolism Lipid metabolism 15 -1.69 0.000 
Pentose phosphate pathway Metabolism Carbohydrate 
metabolism 
18 -1.63 0.000 
Proteasome GIP Folding, sorting and 
degradation 
41 -1.57 0.000 
Fatty acid elongation Metabolism Lipid metabolism 18 -1.55 0.000 
Pyruvate metabolism Metabolism Carbohydrate 
metabolism 
26 -1.55 0.000 
Terpenoid backbone biosynthesis Metabolism Metabolism of 
terpenoids and 
polyketides 
17 -1.54 0.000 
Valine, leucine and isoleucine 
degradation 
Metabolism Amino acid 
metabolism 
36 -1.45 0.000 
Vitamin digestion and absorption Organismal 
Systems 
Digestive system 16 -1.36 0.001 
Glycine, serine and threonine 
metabolism 
Metabolism Amino acid 
metabolism 
31 -1.33 0.001 
Carbon fixation pathways in prokaryotes Metabolism Energy metabolism 11 -1.30 0.003 
Tryptophan metabolism Metabolism Amino acid 
metabolism 
30 -1.16 0.007 
Methane metabolism Metabolism Energy metabolism 14 -1.19 0.007 
Citrate cycle (TCA cycle) Metabolism Carbohydrate 
metabolism 
23 -1.17 0.007 
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Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 -1.14 0.009 
Ubiquitin mediated proteolysis GIP Folding, sorting and 
degradation 
101 1.40 0.010 
Neuroactive ligand-receptor interaction EIP Signaling molecules 
and interaction 
158 1.28 0.012 
SNARE interactions in vesicular 
transport 
GIP Folding, sorting and 
degradation 
27 -1.06 0.015 
Complement and coagulation cascades Organismal 
Systems 
Immune system 59 -1.04 0.019 
Phenylalanine metabolism Metabolism Amino acid 
metabolism 
12 -1.02 0.023 
Glycerolipid metabolism Metabolism Lipid metabolism 26 -1.00 0.023 
Carbon fixation in photosynthetic 
organisms 
Metabolism Energy metabolism 15 -1.01 0.023 
Chemokine signaling pathway Organismal 
Systems 
Immune system 99 1.17 0.025 
Progesterone-mediated oocyte 
maturation 
Organismal 
Systems 
Endocrine system 50 1.17 0.025 
Natural killer cell mediated cytotoxicity Organismal 
Systems 
Immune system 48 1.12 0.034 
Serotonergic synapse Organismal 
Systems 
Nervous system 58 1.08 0.035 
Protein digestion and absorption Organismal 
Systems 
Digestive system 43 1.09 0.035 
B80 vs B0 
Oxidative phosphorylation Metabolism Energy metabolism 106 -3.66 0.000 
Ribosome biogenesis in eukaryotes GIP Translation 63 3.65 0.000 
Proteasome GIP Folding, sorting and 
degradation 
41 -2.86 0.000 
Biosynthesis of unsaturated fatty acids Metabolism Lipid metabolism 15 -2.43 0.000 
Pentose phosphate pathway Metabolism Carbohydrate 
metabolism 
18 -2.22 0.000 
Pyruvate metabolism Metabolism Carbohydrate 
metabolism 
26 -2.18 0.000 
Cardiac muscle contraction Organismal 
Systems 
Circulatory system 49 -2.10 0.000 
Fatty acid elongation Metabolism Lipid metabolism 18 -2.14 0.000 
Propanoate metabolism Metabolism Carbohydrate 
metabolism 
22 -2.05 0.000 
Citrate cycle (TCA cycle) Metabolism Carbohydrate 
metabolism 
23 -1.89 0.000 
Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 -1.80 0.000 
Carbon fixation pathways in prokaryotes Metabolism Energy metabolism 11 -1.84 0.000 
Glyoxylate and dicarboxylate 
metabolism 
Metabolism Carbohydrate 
metabolism 
20 -1.77 0.000 
Glycine, serine and threonine 
metabolism 
Metabolism Amino acid 
metabolism 
31 -1.66 0.000 
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 -1.61 0.000 
Protein export GIP Folding, sorting and 
degradation 
21 1.80 0.000 
Carbon fixation in photosynthetic 
organisms 
Metabolism Energy metabolism 15 -1.56 0.000 
Valine, leucine and isoleucine 
degradation 
Metabolism Amino acid 
metabolism 
36 -1.41 0.000 
Phenylalanine metabolism Metabolism Amino acid 
metabolism 
12 -1.45 0.000 
RNA transport GIP Translation 115 1.55 0.001 
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Vitamin digestion and absorption Organismal 
Systems 
Digestive system 16 -1.40 0.001 
RNA degradation GIP Folding, sorting and 
degradation 
52 1.51 0.001 
mRNA surveillance pathway GIP Translation 54 1.45 0.001 
RNA polymerase GIP Transcription 28 1.40 0.002 
Glycolysis / Gluconeogenesis Metabolism Carbohydrate 
metabolism 
33 -1.27 0.002 
Methane metabolism Metabolism Energy metabolism 14 -1.28 0.002 
Protein digestion and absorption Organismal 
Systems 
Digestive system 43 1.35 0.004 
Neuroactive ligand-receptor interaction EIP Signaling molecules 
and interaction 
158 1.29 0.004 
Cytosolic DNA-sensing pathway Organismal 
Systems 
Immune system 36 1.31 0.004 
ABC transporters EIP Membrane transport 29 -1.18 0.005 
Natural killer cell mediated cytotoxicity Organismal 
Systems 
Immune system 48 1.25 0.005 
Pancreatic secretion Organismal 
Systems 
Digestive system 49 1.26 0.005 
Nicotinate and nicotinamide 
metabolism 
Metabolism Metabolism of 
cofactors and 
vitamins 
14 -1.16 0.006 
Mismatch repair GIP Replication and 
repair 
19 -1.14 0.007 
p53 signaling pathway Cellular 
Processes 
Cell growth and 
death 
45 -1.10 0.009 
Aminoacyl-tRNA biosynthesis GIP Translation 28 -1.09 0.011 
Leukocyte transendothelial migration Organismal 
Systems 
Immune system 65 -1.04 0.014 
Mineral absorption Organismal 
Systems 
Digestive system 27 -1.03 0.015 
Tryptophan metabolism Metabolism Amino acid 
metabolism 
30 -1.02 0.015 
Collecting duct acid secretion Organismal 
Systems 
Excretory system 15 -1.03 0.016 
Cholinergic synapse Organismal 
Systems 
Nervous system 58 1.11 0.017 
Protein processing in endoplasmic 
reticulum 
GIP Folding, sorting and 
degradation 
119 1.10 0.018 
Antigen processing and presentation Organismal 
Systems 
Immune system 32 1.08 0.019 
Pyrimidine metabolism Metabolism Nucleotide 
metabolism 
75 -0.95 0.025 
Fc epsilon RI signaling pathway Organismal 
Systems 
Immune system 31 1.03 0.026 
Serotonergic synapse Organismal 
Systems 
Nervous system 58 1.02 0.026 
Steroid biosynthesis Metabolism Lipid metabolism 14 -0.97 0.027 
Ribosome GIP Translation 119 1.01 0.028 
DNA replication GIP Replication and 
repair 
33 -0.93 0.028 
Chemokine signaling pathway Organismal 
Systems 
Immune system 99 0.99 0.030 
NOD-like receptor signaling pathway Organismal 
Systems 
Immune system 34 0.99 0.031 
Porphyrin and chlorophyll metabolism Metabolism Metabolism of 
cofactors and 
vitamins 
21 -0.88 0.044 
Insulin signaling pathway Organismal Endocrine system 68 -0.86 0.045 
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Systems 
SBM vs B0 
Oxidative phosphorylation Metabolism Energy metabolism 106 -4.33 0.000 
Proteasome GIP Folding, sorting and 
degradation 
41 -4.49 0.000 
Ribosome biogenesis in eukaryotes GIP Translation 63 3.15 0.000 
Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 -2.27 0.000 
Cardiac muscle contraction Organismal 
Systems 
Circulatory system 49 -1.90 0.000 
Citrate cycle (TCA cycle) Metabolism Carbohydrate 
metabolism 
23 -1.79 0.000 
Biosynthesis of unsaturated fatty acids Metabolism Lipid metabolism 15 -1.79 0.000 
Steroid biosynthesis Metabolism Lipid metabolism 14 -1.73 0.001 
Carbon fixation pathways in prokaryotes Metabolism Energy metabolism 11 -1.70 0.001 
Fatty acid elongation Metabolism Lipid metabolism 18 -1.58 0.002 
Natural killer cell mediated cytotoxicity Organismal 
Systems 
Immune system 48 1.60 0.006 
p53 signaling pathway Cellular 
Processes 
Cell growth and 
death 
45 -1.41 0.006 
Mismatch repair GIP Replication and 
repair 
19 -1.41 0.006 
Aminoacyl-tRNA biosynthesis GIP Translation 28 -1.40 0.006 
RNA transport GIP Translation 115 1.50 0.006 
Fc epsilon RI signaling pathway Organismal 
Systems 
Immune system 31 1.52 0.006 
Pyruvate metabolism Metabolism Carbohydrate 
metabolism 
26 -1.39 0.006 
Protein processing in endoplasmic 
reticulum 
GIP Folding, sorting and 
degradation 
119 1.46 0.008 
Antigen processing and presentation Organismal 
Systems 
Immune system 32 1.41 0.010 
mRNA surveillance pathway GIP Translation 54 1.39 0.010 
Peroxisome Cellular 
Processes 
Transport and 
catabolism 
64 1.35 0.013 
Pentose phosphate pathway Metabolism Carbohydrate 
metabolism 
18 -1.30 0.013 
Collecting duct acid secretion Organismal 
Systems 
Excretory system 15 -1.28 0.016 
Synaptic vesicle cycle Organismal 
Systems 
Nervous system 38 -1.23 0.017 
DNA replication GIP Replication and 
repair 
33 -1.22 0.018 
Protein digestion and absorption Organismal 
Systems 
Digestive system 43 1.29 0.023 
Alanine, aspartate and glutamate 
metabolism 
Metabolism Amino acid 
metabolism 
25 1.23 0.031 
Endocrine and other factor-regulated 
calcium reabsorption 
Organismal 
Systems 
Excretory system 24 -1.10 0.045 
Pyrimidine metabolism Metabolism Nucleotide 
metabolism 
75 -1.07 0.046 
Fanconi anemia pathway GIP Replication and 
repair 
43 -1.07 0.046 
Mineral absorption Organismal 
Systems 
Digestive system 27 -1.06 0.049 
Q Value is the p value adjusted for multiple corrections (Benjamini & Hochberg). Pathways are 837 
ordered by decreasing significance.  838 
Magnitude is the average of individual statistics and denotes how affected was the pathway.  839 
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Pathways, Biological Processes and Class are as per KEGG classification.  840 
Number of Genes indicates the genes tested for the specific gene-set. 841 
GIP is Genetic Information Processing 842 
EIP is Environmental Information Processing 843 
  844 
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Supplementary Table 3. Results of GSEA (2d test) of treatments compared to B0.  845 
Gene Set Biological 
Process 
Class Number 
of genes 
Magnitude q Value 
B20 vs B0      
Steroid biosynthesis Metabolism Lipid metabolism 14 1.54 0.005 
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 1.36 0.010 
B40 vs B0      
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 1.92 0.000 
Steroid biosynthesis Metabolism Lipid metabolism 14 1.58 0.002 
Amino sugar and nucleotide sugar 
metabolism 
Metabolism Carbohydrate metabolism 36 1.18 0.041 
Complement and coagulation 
cascades 
Organismal 
Systems 
Immune system 59 1.13 0.046 
B60 vs B0      
Steroid biosynthesis Metabolism Lipid metabolism 14 2.73 0.000 
Complement and coagulation 
cascades 
Organismal 
Systems 
Immune system 59 2.43 0.000 
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 1.99 0.000 
Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 1.99 0.000 
Pyruvate metabolism Metabolism Carbohydrate metabolism 26 1.86 0.000 
Methane metabolism Metabolism Energy metabolism 14 1.93 0.000 
Glycolysis / Gluconeogenesis Metabolism Carbohydrate metabolism 33 1.74 0.000 
Biosynthesis of unsaturated fatty 
acids 
Metabolism Lipid metabolism 15 1.83 0.000 
Glyoxylate and dicarboxylate 
metabolism 
Metabolism Carbohydrate metabolism 20 1.69 0.000 
Oxidative phosphorylation Metabolism Energy metabolism 106 1.57 0.000 
Propanoate metabolism Metabolism Carbohydrate metabolism 22 1.54 0.000 
Pentose phosphate pathway Metabolism Carbohydrate metabolism 18 1.53 0.000 
Insulin signaling pathway Organismal 
Systems 
Endocrine system 68 1.47 0.000 
Fat digestion and absorption Organismal 
Systems 
Digestive system 19 1.52 0.000 
Glycine, serine and threonine 
metabolism 
Metabolism Amino acid metabolism 31 1.42 0.001 
Citrate cycle (TCA cycle) Metabolism Carbohydrate metabolism 23 1.34 0.002 
Carbon fixation pathways in 
prokaryotes 
Metabolism Energy metabolism 11 1.35 0.002 
Metabolism of xenobiotics by 
cytochrome P450 
Metabolism Xenobiotics 
biodegradation and 
metabolism 
12 1.35 0.002 
Glycerolipid metabolism Metabolism Lipid metabolism 26 1.26 0.003 
One carbon pool by folate Metabolism Metabolism of cofactors 
and vitamins 
13 1.27 0.003 
Fatty acid elongation Metabolism Lipid metabolism 18 1.24 0.004 
Terpenoid backbone biosynthesis Metabolism Metabolism of terpenoids 
and polyketides 
17 1.22 0.004 
Starch and sucrose metabolism Metabolism Carbohydrate metabolism 23 1.19 0.005 
Arginine and proline metabolism Metabolism Amino acid metabolism 39 1.14 0.006 
Aminoacyl-tRNA biosynthesis GIP Translation 28 1.15 0.007 
Carbon fixation in photosynthetic Metabolism Energy metabolism 15 1.12 0.009 
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organisms 
Steroid hormone biosynthesis Metabolism Lipid metabolism 24 1.08 0.010 
Amino sugar and nucleotide sugar 
metabolism 
Metabolism Carbohydrate metabolism 36 1.07 0.010 
Cardiac muscle contraction Organismal 
Systems 
Circulatory system 49 1.05 0.011 
Vitamin digestion and absorption Organismal 
Systems 
Digestive system 16 1.06 0.011 
Pentose and glucuronate 
interconversions 
Metabolism Carbohydrate metabolism 14 0.93 0.033 
Phagosome Cellular 
Processes 
Transport and catabolism 79 0.88 0.038 
Carbohydrate digestion and 
absorption 
Organismal 
Systems 
Digestive system 16 0.87 0.045 
B80 vs B0      
Steroid biosynthesis Metabolism Lipid metabolism 14 3.16 0.000 
Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 2.98 0.000 
Methane metabolism Metabolism Energy metabolism 14 2.34 0.000 
Biosynthesis of unsaturated fatty 
acids 
Metabolism Lipid metabolism 15 2.39 0.000 
Fat digestion and absorption Organismal 
Systems 
Digestive system 19 2.29 0.000 
Oxidative phosphorylation Metabolism Energy metabolism 106 2.09 0.000 
Pyruvate metabolism Metabolism Carbohydrate metabolism 26 2.15 0.000 
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 2.09 0.000 
Glycolysis / Gluconeogenesis Metabolism Carbohydrate metabolism 33 2.00 0.000 
Protein processing in endoplasmic 
reticulum 
GIP Folding, sorting and 
degradation 
119 1.94 0.000 
Glycine, serine and threonine 
metabolism 
Metabolism Amino acid metabolism 31 1.93 0.000 
Glycerolipid metabolism Metabolism Lipid metabolism 26 1.94 0.000 
Pentose phosphate pathway Metabolism Carbohydrate metabolism 18 1.91 0.000 
Pyrimidine metabolism Metabolism Nucleotide metabolism 75 1.79 0.000 
Propanoate metabolism Metabolism Carbohydrate metabolism 22 1.77 0.000 
Fatty acid elongation Metabolism Lipid metabolism 18 1.76 0.000 
Citrate cycle (TCA cycle) Metabolism Carbohydrate metabolism 23 1.64 0.000 
Carbon fixation pathways in 
prokaryotes 
Metabolism Energy metabolism 11 1.70 0.000 
One carbon pool by folate Metabolism Metabolism of cofactors 
and vitamins 
13 1.63 0.000 
Carbon fixation in photosynthetic 
organisms 
Metabolism Energy metabolism 15 1.62 0.000 
Complement and coagulation 
cascades 
Organismal 
Systems 
Immune system 59 1.53 0.000 
Ribosome biogenesis in 
eukaryotes 
GIP Translation 63 1.46 0.000 
Insulin signaling pathway Organismal 
Systems 
Endocrine system 68 1.44 0.000 
Alanine, aspartate and glutamate 
metabolism 
Metabolism Amino acid metabolism 25 1.45 0.000 
Glyoxylate and dicarboxylate 
metabolism 
Metabolism Carbohydrate metabolism 20 1.44 0.000 
Protein export GIP Folding, sorting and 
degradation 
21 1.45 0.000 
Carbohydrate digestion and 
absorption 
Organismal 
Systems 
Digestive system 16 1.39 0.001 
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Pancreatic secretion Organismal 
Systems 
Digestive system 49 1.33 0.001 
Cysteine and methionine 
metabolism 
Metabolism Amino acid metabolism 23 1.30 0.001 
Metabolism of xenobiotics by 
cytochrome P450 
Metabolism Xenobiotics 
biodegradation and 
metabolism 
12 1.29 0.002 
Amino sugar and nucleotide sugar 
metabolism 
Metabolism Carbohydrate metabolism 36 1.22 0.002 
p53 signaling pathway Cellular 
Processes 
Cell growth and death 45 1.19 0.003 
beta-Alanine metabolism Metabolism Metabolism of other 
amino acids 
21 1.16 0.004 
Cardiac muscle contraction Organismal 
Systems 
Circulatory system 49 1.13 0.004 
Arginine and proline metabolism Metabolism Amino acid metabolism 39 1.13 0.005 
Aminoacyl-tRNA biosynthesis GIP Translation 28 1.12 0.005 
Starch and sucrose metabolism Metabolism Carbohydrate metabolism 23 1.10 0.006 
Tyrosine metabolism Metabolism Amino acid metabolism 24 1.07 0.008 
Arachidonic acid metabolism Metabolism Lipid metabolism 24 1.03 0.010 
Vitamin digestion and absorption Organismal 
Systems 
Digestive system 16 1.03 0.011 
Galactose metabolism Metabolism Carbohydrate metabolism 18 1.02 0.012 
Proteasome GIP Folding, sorting and 
degradation 
41 1.02 0.012 
Phagosome Cellular 
Processes 
Transport and catabolism 79 0.96 0.016 
Terpenoid backbone biosynthesis Metabolism Metabolism of terpenoids 
and polyketides 
17 0.97 0.017 
Porphyrin and chlorophyll 
metabolism 
Metabolism Metabolism of cofactors 
and vitamins 
21 0.91 0.027 
Estrogen signaling pathway Organismal 
Systems 
Endocrine system 51 0.89 0.029 
Pentose and glucuronate 
interconversions 
Metabolism Carbohydrate metabolism 14 0.90 0.029 
Antigen processing and 
presentation 
Organismal 
Systems 
Immune system 32 0.88 0.030 
Primary bile acid biosynthesis Metabolism Lipid metabolism 13 0.87 0.035 
Lysosome Cellular 
Processes 
Transport and catabolism 89 0.80 0.048 
SBM vs B0      
Steroid biosynthesis Metabolism Lipid metabolism 14 2.82 0.000 
Glutathione metabolism Metabolism Metabolism of other 
amino acids 
23 2.59 0.000 
Proteasome GIP Folding, sorting and 
degradation 
41 2.37 0.000 
Pyrimidine metabolism Metabolism Nucleotide metabolism 75 2.16 0.000 
Protein processing in endoplasmic 
reticulum 
GIP Folding, sorting and 
degradation 
119 2.12 0.000 
Oxidative phosphorylation Metabolism Energy metabolism 106 1.98 0.000 
PPAR signaling pathway Organismal 
Systems 
Endocrine system 44 1.90 0.000 
Fat digestion and absorption Organismal 
Systems 
Digestive system 19 1.79 0.000 
Methane metabolism Metabolism Energy metabolism 14 1.77 0.000 
Biosynthesis of unsaturated fatty 
acids 
Metabolism Lipid metabolism 15 1.79 0.000 
Glycolysis / Gluconeogenesis Metabolism Carbohydrate metabolism 33 1.69 0.000 
45 
 
Pentose phosphate pathway Metabolism Carbohydrate metabolism 18 1.66 0.001 
Pyruvate metabolism Metabolism Carbohydrate metabolism 26 1.59 0.001 
Ribosome biogenesis in 
eukaryotes 
GIP Translation 63 1.54 0.001 
DNA replication GIP Replication and repair 33 1.51 0.002 
Insulin signaling pathway Organismal 
Systems 
Endocrine system 68 1.43 0.003 
Cysteine and methionine 
metabolism 
Metabolism Amino acid metabolism 23 1.42 0.004 
Glycerolipid metabolism Metabolism Lipid metabolism 26 1.41 0.004 
Fatty acid elongation Metabolism Lipid metabolism 18 1.42 0.005 
Protein export GIP Folding, sorting and 
degradation 
21 1.38 0.005 
p53 signaling pathway Cellular 
Processes 
Cell growth and death 45 1.33 0.006 
Propanoate metabolism Metabolism Carbohydrate metabolism 22 1.33 0.007 
Purine metabolism Metabolism Nucleotide metabolism 113 1.27 0.008 
Alanine, aspartate and glutamate 
metabolism 
Metabolism Amino acid metabolism 25 1.29 0.008 
Amino sugar and nucleotide sugar 
metabolism 
Metabolism Carbohydrate metabolism 36 1.28 0.008 
Terpenoid backbone biosynthesis Metabolism Metabolism of terpenoids 
and polyketides 
17 1.25 0.013 
Aminoacyl-tRNA biosynthesis GIP Translation 28 1.23 0.013 
Glycine, serine and threonine 
metabolism 
Metabolism Amino acid metabolism 31 1.17 0.017 
Metabolism of xenobiotics by 
cytochrome P450 
Metabolism Xenobiotics 
biodegradation and 
metabolism 
12 1.21 0.017 
Carbon fixation in photosynthetic 
organisms 
Metabolism Energy metabolism 15 1.14 0.022 
Carbon fixation pathways in 
prokaryotes 
Metabolism Energy metabolism 11 1.16 0.022 
Folate biosynthesis Metabolism Metabolism of cofactors 
and vitamins 
10 1.16 0.022 
Arginine and proline metabolism Metabolism Amino acid metabolism 39 1.11 0.023 
Primary bile acid biosynthesis Metabolism Lipid metabolism 13 1.13 0.024 
One carbon pool by folate Metabolism Metabolism of cofactors 
and vitamins 
13 1.12 0.024 
Starch and sucrose metabolism Metabolism Carbohydrate metabolism 23 1.07 0.029 
Various types of N-glycan 
biosynthesis 
Metabolism Glycan biosynthesis and 
metabolism 
24 1.01 0.043 
Citrate cycle (TCA cycle) Metabolism Carbohydrate metabolism 23 0.98 0.050 
Q Value is the p value adjusted for multiple corrections (Benjamini & Hochberg). Pathways are 846 
ordered by decreasing significance.  847 
Magnitude is the average of individual statistics and denotes how affected was the pathway.  848 
Pathways, Biological Processes and Class are as per KEGG classification.  849 
Number of Genes indicates the genes tested for the specific gene-set. 850 
GIP is Genetic Information Processing 851 
 852 
 853 
